Navigation Links
Eloxatin combination reduces bowel cancer recurrences

Bowel cancer is one of the most common cancers occurring in humans. A clinical study involving patients taking supplementation of Eloxatin drug with other chemotherapeutic cancer drug for treatment of bowel // cancer has found better prognosis and reduced recurrence in these patients. This study which is called as NICE study has proved a combination of Eloxatin with chemotherapeutic drugs more effective than control group which received only cancer chemotherapeutic drug such as 5-Fluorouracil and Folinic acid.

The study has found combination of Eloxatin with 5-Fluorouracil and Folinic acid more effective in treating early bowel cancer compared to control group. International trials show that adding Eloxatin to the standard chemotherapy combination helps reduce the risk of relapse after surgery by 25%.

Experts View:

Hilary Whitaker, chief executive of Beating Bowel Cancer said, "It's impossible to overstate the importance of this decision by NICE for the thousands of people diagnosed every year with early stage bowel cancer and we want all eligible patients to have access to the best chance of cure and although the final guidance may take some months to be confirmed, patients should start speaking now to their clinicians to ensure that they are offered the option of the most effective treatment for their particular type of bowel cancer."

Dr Harpreet Wasan, medical oncologist at Hammersmith Hospital in London said, "This is a landmark decision by NICE in the treatment of bowel cancer, which will be welcomed by clinicians and patients alike.”

Source: BBC News.
'"/>




Page: 1

Related medicine news :

1. The bad combination
2. Warding off symptoms of premenstrual syndrome by combination therapy
3. Cholesterol can be lowered using combination of Soy Proteins and Sterols
4. Nanocells cancer combination therapy acts as chemotherapy as well as anti-angiogenic drug
5. Calcitriol [Vitamin D] with combination of painkillers for cancer treatment
6. Chloroquine and Primaquine combination Malarial drug for resistant parasites.
7. Death from heart attack can be reduced by new drug combination
8. New tetanus-diphtheria combination vaccine launched by Serum Institute of India
9. More effective Antiretroviral HIV drug combination
10. Salmeterol - to be used in combination & only when required
11. New chemo combination to fight breast cancer better

Post Your Comments:
(Date:11/27/2009)...w-emission vehicles may reduce future disease burd...(HealthDay News) -- Encouraging city dwellers to w...much greater public health benefits than increased...ave found. , The study compared the projected h...ansport scenarios for London, England, and Delhi, ...
(Date:11/27/2009)...ulti-purpose bilingual coloring books designed for...siness community to educate - inform parents and c... issues to Dinosuars to ABC,S and a host of other ... (PRWEB) November 27, 2009 -- Today’s childr...p them busy any hour of the day, but one of the ol...
(Date:11/26/2009)...J., Nov. 27 The diabetes populatio... next 25 years and annual medical spending on the ...$113 billion today, according to a study published...tional Changing Diabetes ® Program (NCDP), a...s by a team from the University of Chicago. ,, ...
(Date:11/26/2009)...en on an emotional rollercoaster, study finds , ...ll it the fear factor meets the jubilant sports fa...pecially those who root for the winning team -- en...ntested match and victory was in doubt, producing ...hat this Thanksgiving weekend as you,re glued to t...
(Date:11/26/2009)...enton Communications announces a highly effective ...ilers struggling to make an economic recovery. , ...-- Flu fears is the type of challenge that could s...cording to Dr. David Benton, business growth exper... system – The Rfactor Intensive . “...
Breaking Medicine News(10 mins):Health News:More Foot Power, Less Car Pollution Best for Health 2Health News:Really Big Coloring Books Debuts Bi-Lingual Spanish-English Line of Custom and Imprintable Coloring Books 2Health News:Diabetes Population to Double, Diabetes Costs to Nearly Triple, in 25 Years, New Study Shows 2Health News:Diabetes Population to Double, Diabetes Costs to Nearly Triple, in 25 Years, New Study Shows 3Health News:Diabetes Population to Double, Diabetes Costs to Nearly Triple, in 25 Years, New Study Shows 4Health News:Watching the Nail-Biting Big Game Hurts So Good 2Health News:Watching the Nail-Biting Big Game Hurts So Good 3Health News:Pharmacist Injects Cure for Ailing Businesses 2
...US bone graft substitute market to reach almost ...esearch Group, WALTHAM, Mass., May 14 With the a...ss, NuVasive has obtained the first,off-the-shelf ...l drive the BGS market to $1.9 billion in 2012,acc...
... PBTF Institute at Duke accelerates search for ...C., May 14 The Pediatric Brain,Tumor Foundation (...its,research institute at Duke University, bringin...use the funds to continue to sharpen its research ...
...s 2 to 3 times faster, dramatically boosting survi...) -- Researchers report they have dramatically inc...aused by bleeding within the brain by fine-tuning ...h rate in patients with this condition to an 80 pe...
...tensive people in morning use, researchers report ...A daily aspirin can control prehypertension, but o...ws. , An aspirin taken every morning didn,t lower ...sion annual meeting, in New Orleans. , A previous ...
...d primary teacher, hits five cities in one ... Joshua Rosenthal, founder and primary,teacher of ...,s largest,nutrition school, is hosting a public l...s and also discuss the,challenges and opportunitie...
...traZeneca (NYSE:,AZN) today announced that the U.S...SEROQUEL(R) (quetiapine fumarate tablets) for the ...isorder, as adjunct therapy to,lithium or divalpro...h depressive episodes in bipolar disorder and acut...
Other Medicine News:Health News:NuVasive Acquires First Stem Cell Bone Graft Substitute 2Health News:NuVasive Acquires First Stem Cell Bone Graft Substitute 3Health News:Video: Pediatric Brain Tumor Foundation Gives $6 Million Grant to Duke 2Health News:Clot-Busting Treatment Improves Bleeding Stroke Outcomes 2Health News:Aspirin at Bedtime Lowers Blood Pressure 2Health News:Institute for Integrative Nutrition Begins Road Tour 2Health News:FDA Approves AstraZeneca's Seroquel(R) for Maintenance Treatment in Bipolar Disorder 2Health News:FDA Approves AstraZeneca's Seroquel(R) for Maintenance Treatment in Bipolar Disorder 3Health News:FDA Approves AstraZeneca's Seroquel(R) for Maintenance Treatment in Bipolar Disorder 4Health News:FDA Approves AstraZeneca's Seroquel(R) for Maintenance Treatment in Bipolar Disorder 5Health News:FDA Approves AstraZeneca's Seroquel(R) for Maintenance Treatment in Bipolar Disorder 6Health News:FDA Approves AstraZeneca's Seroquel(R) for Maintenance Treatment in Bipolar Disorder 7Health News:FDA Approves AstraZeneca's Seroquel(R) for Maintenance Treatment in Bipolar Disorder 8Health News:FDA Approves AstraZeneca's Seroquel(R) for Maintenance Treatment in Bipolar Disorder 9
(Date:11/25/2009)...PRNewswire/ -- BioTrends Research Group, Inc. rele... report, the first in a multi-phase syndicated m...ocor Ortho-Biotech,s Stelara, from product launch ...h wave of the report provides quantitative informa... information from a subset of 20. The reports ass...
(Date:11/25/2009)..., Nov. 25 AMPAC Fine Chemicals LLC...on (Nasdaq: APFC ) announced today that it receiv...lity Award at the Annual Statewide Environmental S...nd Technology Association (CMTA), the Industrial E...dustry Council of California (CICC) held in San Di...
(Date:11/25/2009)...5 Reportlinker.com announces that ...atalogue: ,, Mammography Equipment - A Global...er.com/p0164330/Mammography-Equipment---A-Global-M...breast cancer in industrialized as well as develop...th in the mammography market. Globally, escalating...
Breaking Medicine Technology:Despite Managed Care Obstacles, Interest and Anticipated Use of Centocor Ortho-Biotech's New Psoriasis Agent Stelara (ustekinumab) is High 2AMPAC Fine Chemicals Receives Prestigious Award at California's Annual Statewide Environmental Summit 2AMPAC Fine Chemicals Receives Prestigious Award at California's Annual Statewide Environmental Summit 3Reportlinker Adds Mammography Equipment - A Global Market Perspective 2Reportlinker Adds Mammography Equipment - A Global Market Perspective 3Reportlinker Adds Mammography Equipment - A Global Market Perspective 4Reportlinker Adds Mammography Equipment - A Global Market Perspective 5Reportlinker Adds Mammography Equipment - A Global Market Perspective 6Reportlinker Adds Mammography Equipment - A Global Market Perspective 7Reportlinker Adds Mammography Equipment - A Global Market Perspective 8ISSA Recognized as Military Friendly School 57294 1ISSA Recognized as Military Friendly School 57294 2Nanophotonic devices could revolutionize the telecommunications industry 14067 1Nanophotonic devices could revolutionize the telecommunications industry 14067 2InSound Medical Kicks Off 26quot 3BTell Us Your Story 26quot 3B Contest 57289 1InSound Medical Kicks Off 26quot 3BTell Us Your Story 26quot 3B Contest 57289 2
...t in patients with pulmonary arterial hyperte...limited benefit for this debilitating, rapidl... -- Imatinib mesylate, available as Gleevec(R) f...ibit protein associated with PAH, -- Novartis t...n PAH in 2009 EAST HANOVER, N.J., Oct. 8 An...
...detecting polyps that can be ... At the American College of,Gastroenterology Annu...ned,gastroenterologist Douglas K. Rex, MD presente...y that evaluated the efficacy of the Third,Eye(R) ...prove the ability,of physicians to detect abnormal...
Other Medicine Technology:Early Data Show Potential for Imatinib Mesylate Tablets to Treat Life-Threatening Form of Pulmonary Artery Disease 2Early Data Show Potential for Imatinib Mesylate Tablets to Treat Life-Threatening Form of Pulmonary Artery Disease 3Early Data Show Potential for Imatinib Mesylate Tablets to Treat Life-Threatening Form of Pulmonary Artery Disease 4Early Data Show Potential for Imatinib Mesylate Tablets to Treat Life-Threatening Form of Pulmonary Artery Disease 5Early Data Show Potential for Imatinib Mesylate Tablets to Treat Life-Threatening Form of Pulmonary Artery Disease 6Early Data Show Potential for Imatinib Mesylate Tablets to Treat Life-Threatening Form of Pulmonary Artery Disease 7Early Data Show Potential for Imatinib Mesylate Tablets to Treat Life-Threatening Form of Pulmonary Artery Disease 8Early Data Show Potential for Imatinib Mesylate Tablets to Treat Life-Threatening Form of Pulmonary Artery Disease 9Early Data Show Potential for Imatinib Mesylate Tablets to Treat Life-Threatening Form of Pulmonary Artery Disease 10Early Data Show Potential for Imatinib Mesylate Tablets to Treat Life-Threatening Form of Pulmonary Artery Disease 11Early Data Show Potential for Imatinib Mesylate Tablets to Treat Life-Threatening Form of Pulmonary Artery Disease 12National Study Presented at ACG 2008 Confirms New Device Functions Like 'Rear-View Mirror' to Provide Improved View of the Colon 2National Study Presented at ACG 2008 Confirms New Device Functions Like 'Rear-View Mirror' to Provide Improved View of the Colon 3National Study Presented at ACG 2008 Confirms New Device Functions Like 'Rear-View Mirror' to Provide Improved View of the Colon 4National Study Presented at ACG 2008 Confirms New Device Functions Like 'Rear-View Mirror' to Provide Improved View of the Colon 5
Atraumatic Grasping Forceps (Fallopian), dual-incision
Optima III 45 Noninsulated Strong Forceps, with ratchet
Snap-In Snap-Out®-II Angulated Dissecting Forceps
Snap-In Snap-Out®-II Micro Dolphin Dissecting Forceps Insert
Medicine Products: